Health state valuation in low- and middle-income countries: A systematic review of the literature

Kularatna S., Whitty J.A., Johnson N.W. and Scuffham P.A. (2013) Health state valuation in low- and middle-income countries: A systematic review of the literature. Value in Health, 16 6: 1091-1099. doi:10.1016/j.jval.2013.05.006


Author Kularatna S.
Whitty J.A.
Johnson N.W.
Scuffham P.A.
Title Health state valuation in low- and middle-income countries: A systematic review of the literature
Journal name Value in Health   Check publisher's open access policy
ISSN 1098-3015
1524-4733
Publication date 2013-09-01
Year available 2013
Sub-type Critical review of research, literature review, critical commentary
DOI 10.1016/j.jval.2013.05.006
Open Access Status DOI
Volume 16
Issue 6
Start page 1091
End page 1099
Total pages 9
Place of publication New York, United States
Publisher Elsevier Inc
Language eng
Subject 2719 Health Policy
2739 Public Health, Environmental and Occupational Health
Formatted abstract
Objective Cost-utility analysis is widely used in high-income countries to inform decisions on efficient health care resource allocation. Cost-utility analysis uses the quality-adjusted life-year as the outcome measure of health. High-income countries have undertaken health state valuation (HSV) studies to determine country-specific utility weights to facilitate valuation of health-related quality of life. Despite an evident need, however, the extent of HSVs in low- and middle-income countries (LMICs) is unclear.
Methods The literature was searched systematically by using four databases and additional Web searches to identify HSV studies carried out in LMICs. The Preferred Reporting System for Systematic Reviews and Meta-Analysis (PRISMA) strategy was followed to ensure systematic selection of the articles.
Results The review identified 17 HSV studies from LMICs. Twelve studies were undertaken in upper middle-income countries, while lower middle- and low-income countries contributed three and two studies, respectively. There were 7 generic HSV and 10 disease-specific HSV studies. The seven generic HSVs included five EuroQol five-dimensional questionnaire, one six-dimensional health state short form (derived from short-form 36 health survey), and one Assessment of Quality of Life valuations. Time trade-off was the predominant valuation method used across all studies.
Conclusions This review found that health state valuations from LMICs are uncommon and utility weights are generally unavailable for these countries to carry out health economic evaluation. More HSV studies need to be undertaken in LMICs to facilitate efficient resource allocation in their respective health systems.
Keyword health state valuation LMIC preference QALY utility
Q-Index Code C1
Q-Index Status Confirmed Code
Institutional Status Non-UQ

Document type: Journal Article
Sub-type: Critical review of research, literature review, critical commentary
Collections: Non HERDC
School of Pharmacy Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 10 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 11 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Wed, 12 Mar 2014, 19:08:56 EST by System User on behalf of School of Pharmacy